00512 GRAND PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.22X | Oper Margin | 24.8% |
|---|---|---|---|
| LT Debt/Equity | 7.9% | Net Margin | 21.2% |
| Total Debt/Equity | 27.0% | Return on Equity | 15.0% |
| Price/Book | 2.03X | Return on Assets | 9.9% |
| (HKD 9.400) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,468.38 | 1,880.00 | 2,079.42 | 2,402.56 | 1,792.66 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +31.3 | -9.6 | -13.5 | +34.0 | +55.8 |
| Earnings Per Share (HKD) | 0.705 | 0.536 | 0.587 | 0.677 | 0.52 |
| Earnings Per Share Growth (%) | +31.5 | -8.7 | -13.3 | +30.2 | +48.2 |
| Dividend Per Share (HKD) | 0.260 | 0.260 | 0.140 | 0.110 | 0.110 |
| P/E* (X) | 13.34 | 17.54 | 16.01 | 13.88 | 18.07 |
| Yield (%) | 2.77 | 2.77 | 1.49 | 1.17 | 1.17 |
| Dividend Share (%) | 36.88 | 48.51 | 23.85 | 16.24 | 21.14 |
| Book NAV (HKD) | 4.641 | 4.270 | 3.984 | 3.773 | 3.166 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 11,645 | 10,530 | +10.6 | 9,562 |
| Operating Result | 2,704 | 2,369 | +14.1 | 2,561 |
| Associates | 148.72 | -25.008 | -694.7 | -43.786 |
| Profit Before Taxation | 2,852 | 2,344 | +21.7 | 2,517 |
| Taxation | 386.304 | 448.755 | -13.9 | 418.642 |
| Profit /( Loss) After Taxation | 2,466 | 1,895 | +30.1 | 2,098 |
| Minority Interests | -2.316 | 15.444 | -115.0 | 18.832 |
| Net Profit | 2,468 | 1,880 | +31.3 | 2,079 |
| Earnings Per Share () | 0.7049 | 0.5360 | +31.5 | 0.5870 |
| Dividend Per Share () | 0.2600 | 0.2600 | +0.0 | 0.1400 |
| Announcement Date | 2025-03-12 | 2024-03-20 | NA | 2023-03-22 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
